S&P 500   4,179.83
DOW   32,908.27
QQQ   347.99
Alibaba Unveils Its Spin-Off Plans
This NASDAQ Stock Is The Amazon Of Medical Supply (Ad)
The Most Upgraded Stocks From The Q1 Earnings Season
Oman launches $5B investment fund as part of efforts to diversify oil-dependant economy
This NASDAQ Stock Is The Amazon Of Medical Supply (Ad)
Can the Dow's 2023 Runaway Winners Keep Running?
KLA Shares Soars As Chip Equipment Makers Surge 21% In May
Lithium Has Boomed And This American Stock Is Ready.. (Ad)
Can These Two Crypto Stocks Stage a Comeback?
Advance Auto Parts Backfires: Is This A Warning For The S&P 500?
S&P 500   4,179.83
DOW   32,908.27
QQQ   347.99
Alibaba Unveils Its Spin-Off Plans
This NASDAQ Stock Is The Amazon Of Medical Supply (Ad)
The Most Upgraded Stocks From The Q1 Earnings Season
Oman launches $5B investment fund as part of efforts to diversify oil-dependant economy
This NASDAQ Stock Is The Amazon Of Medical Supply (Ad)
Can the Dow's 2023 Runaway Winners Keep Running?
KLA Shares Soars As Chip Equipment Makers Surge 21% In May
Lithium Has Boomed And This American Stock Is Ready.. (Ad)
Can These Two Crypto Stocks Stage a Comeback?
Advance Auto Parts Backfires: Is This A Warning For The S&P 500?
S&P 500   4,179.83
DOW   32,908.27
QQQ   347.99
Alibaba Unveils Its Spin-Off Plans
This NASDAQ Stock Is The Amazon Of Medical Supply (Ad)
The Most Upgraded Stocks From The Q1 Earnings Season
Oman launches $5B investment fund as part of efforts to diversify oil-dependant economy
This NASDAQ Stock Is The Amazon Of Medical Supply (Ad)
Can the Dow's 2023 Runaway Winners Keep Running?
KLA Shares Soars As Chip Equipment Makers Surge 21% In May
Lithium Has Boomed And This American Stock Is Ready.. (Ad)
Can These Two Crypto Stocks Stage a Comeback?
Advance Auto Parts Backfires: Is This A Warning For The S&P 500?
S&P 500   4,179.83
DOW   32,908.27
QQQ   347.99
Alibaba Unveils Its Spin-Off Plans
This NASDAQ Stock Is The Amazon Of Medical Supply (Ad)
The Most Upgraded Stocks From The Q1 Earnings Season
Oman launches $5B investment fund as part of efforts to diversify oil-dependant economy
This NASDAQ Stock Is The Amazon Of Medical Supply (Ad)
Can the Dow's 2023 Runaway Winners Keep Running?
KLA Shares Soars As Chip Equipment Makers Surge 21% In May
Lithium Has Boomed And This American Stock Is Ready.. (Ad)
Can These Two Crypto Stocks Stage a Comeback?
Advance Auto Parts Backfires: Is This A Warning For The S&P 500?
NASDAQ:MDXH

MDxHealth (MDXH) Stock Forecast, Price & News

$3.64
+0.05 (+1.39%)
(As of 05/31/2023 ET)
Compare
Today's Range
$3.54
$3.77
50-Day Range
$2.85
$4.20
52-Week Range
$2.47
$9.49
Volume
140,849 shs
Average Volume
234,163 shs
Market Capitalization
$59.30 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$11.67

MDxHealth MarketRank™ Forecast

Analyst Rating
Buy
3.00 Rating Score
Upside/​Downside
188.5% Upside
$10.50 Price Target
Short Interest
Healthy
0.51% of Float Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
N/A
Insider Trading
N/A
Proj. Earnings Growth
Growing
From ($1.40) to ($1.13) Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.14 out of 5 stars

Medical Sector

472nd out of 1,006 stocks

Medical Laboratories Industry

12th out of 24 stocks


MDXH stock logo

About MDxHealth (NASDAQ:MDXH) Stock

MDxHealth SA, a commercial-stage precision diagnostics company, provides urologic solutions in the United States, the Netherlands, Belgium, Spain, Poland, Italy, rest of European Union, and internationally. Its novel prostate cancer genomic testing solutions are SelectMDx, a non-invasive urine test; and ConfirmMDx, an epigenetic test, which provide physicians with a clinical pathway to identify clinically prostate cancer while minimizing the use of invasive procedures that are prone to complications. The company was formerly known as OncoMethylome Sciences SA and changed its name to MDxHealth SA in October 2010. MDxHealth SA was incorporated in 2003 and is headquartered in Herstal, Belgium.

Receive MDXH Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for MDxHealth and its competitors with MarketBeat's FREE daily newsletter.

MDXH Stock News Headlines

We Called (ARWR) In Advance, Which Stocks Are Next?
Nearly 56% gains in 30 days! This bullish trend reversal was not only forecasted by A.I., but we called it 1 – 3 days in advance. If you have any money invested in the markets…even just your retirement, you’ll want to see this. Plus, it’s FREE - the training is only an hour & LIVE.
mdxhealth: MDxHealth Reports Q1-2023 Results
We Called (ARWR) In Advance, Which Stocks Are Next?
Nearly 56% gains in 30 days! This bullish trend reversal was not only forecasted by A.I., but we called it 1 – 3 days in advance. If you have any money invested in the markets…even just your retirement, you’ll want to see this. Plus, it’s FREE - the training is only an hour & LIVE.
MDxHealth Reports Q1-2023 Results
MDxHealth earnings preview: what Wall Street is expecting
Short Volatility Alert: Mdxhealth
Foundational LCD Covers Select mdx for Prostate Cancer
Contrasting MDxHealth (MDXH) and Its Competitors
Contrasting MDxHealth (MDXH) & Its Competitors
Head to Head Analysis: MDxHealth (MDXH) vs. The Competition
Critical Analysis: MDxHealth (MDXH) & Its Rivals
MDxHealth (MDXH) & Its Rivals Head to Head Survey
Contrasting MDxHealth (MDXH) and The Competition
See More Headlines
Receive MDXH Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for MDxHealth and its competitors with MarketBeat's FREE daily newsletter.

MDXH Company Calendar

Last Earnings
3/08/2023
Today
5/31/2023
Next Earnings (Estimated)
8/24/2023
Fiscal Year End
12/31/2023

Industry, Sector and Symbol

Industry
Medical laboratories
Sub-Industry
N/A
Sector
Medical
Current Symbol
NASDAQ:MDXH
Fax
N/A
Employees
N/A
Year Founded
N/A

Price Target and Rating

Average Stock Price Forecast
$10.50
High Stock Price Forecast
$18.00
Low Stock Price Forecast
$7.00
Forecasted Upside/Downside
+220.5%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
5 Analysts

Profitability

Net Income
$-44,040,000.00
Net Margins
-104.02%
Pretax Margin
-118.86%

Debt

Sales & Book Value

Annual Sales
$37.05 million
Book Value
$2.31 per share

Miscellaneous

Free Float
N/A
Market Cap
$59.30 million
Optionable
Not Optionable
Beta
0.24

Key Executives

  • Mr. Michael K. McGarrity (Age 59)
    CEO & Exec. Director
    Comp: $502.44k
  • Mr. Ron Kalfus (Age 48)
    Chief Financial Officer
  • Mr. Joseph Sollee (Age 57)
    Exec. VP of Corp. Devel. & Gen. Counsel
  • Mr. John A. Bellano (Age 53)
    Chief Commercial Officer
  • Ms. Miriam Reyes (Age 49)
    Exec. VP of Operations
  • Dr. Wim Van Criekinge (Age 50)
    Chief Scientific Officer
  • Mr. Paul Marr
    Exec. VP of Sales for North America













MDXH Stock - Frequently Asked Questions

Should I buy or sell MDxHealth stock right now?

5 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for MDxHealth in the last twelve months. There are currently 5 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "buy" MDXH shares.
View MDXH analyst ratings
or view top-rated stocks.

What is MDxHealth's stock price forecast for 2023?

5 equities research analysts have issued 1-year target prices for MDxHealth's shares. Their MDXH share price forecasts range from $7.00 to $18.00. On average, they predict the company's share price to reach $10.50 in the next year. This suggests a possible upside of 188.5% from the stock's current price.
View analysts price targets for MDXH
or view top-rated stocks among Wall Street analysts.

How have MDXH shares performed in 2023?

MDxHealth's stock was trading at $6.61 at the beginning of the year. Since then, MDXH stock has decreased by 44.9% and is now trading at $3.64.
View the best growth stocks for 2023 here
.

When is MDxHealth's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Thursday, August 24th 2023.
View our MDXH earnings forecast
.

How were MDxHealth's earnings last quarter?

MDxHealth SA (NASDAQ:MDXH) posted its quarterly earnings results on Wednesday, March, 8th. The company reported ($1.10) earnings per share for the quarter, missing analysts' consensus estimates of ($0.75) by $0.35. The company had revenue of $12.89 million for the quarter, compared to analyst estimates of $14.76 million. MDxHealth had a negative trailing twelve-month return on equity of 193.40% and a negative net margin of 104.02%.

When did MDxHealth IPO?

(MDXH) raised $45 million in an initial public offering on Thursday, November 4th 2021. The company issued 3,750,000 shares at a price of $12.00 per share.

What is MDxHealth's stock symbol?

MDxHealth trades on the NASDAQ under the ticker symbol "MDXH."

Who are MDxHealth's major shareholders?

MDxHealth's stock is owned by a number of institutional and retail investors. Top institutional shareholders include Alyeska Investment Group L.P. (3.68%), Hood River Capital Management LLC (3.55%), Ally Bridge Group NY LLC (3.07%), Element Capital Management LLC (2.63%), Perkins Capital Management Inc. (2.51%) and Sei Investments Co. (1.03%).
View institutional ownership trends
.

How do I buy shares of MDxHealth?

Shares of MDXH stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is MDxHealth's stock price today?

One share of MDXH stock can currently be purchased for approximately $3.64.

How much money does MDxHealth make?

MDxHealth (NASDAQ:MDXH) has a market capitalization of $59.30 million and generates $37.05 million in revenue each year. The company earns $-44,040,000.00 in net income (profit) each year or ($1.90) on an earnings per share basis.

How can I contact MDxHealth?

MDxHealth's mailing address is CAP Business Center, Herstal, Liege 4040. The official website for the company is mdxhealth.com. The company can be reached via phone at 324-364-2070 or via email at ir@mdxhealth.com.

This page (NASDAQ:MDXH) was last updated on 6/1/2023 by MarketBeat.com Staff

My Account -